China Pharma Holdings
CPHI
5 hedge funds and large institutions have $212K invested in China Pharma Holdings in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.
140% more capital invested
Capital invested by funds: $88.3K → $212K (+$123K)
3.46% more ownership
Funds ownership: 0.18% → 3.64% (+3.5%)
17% less funds holding
Funds holding: 6 → 5 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$112K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$32.6K |
| 3 |
HF
HRT Financial
New York
|
+$25.1K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$15.1K |
| 5 |
DB
Danske Bank
Copenhagen K,
Denmark
|
+$2 |
Top Sellers
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$22K |
| 2 |
Renaissance Technologies
New York
|
-$12.1K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$6.67K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $128K | +$112K | +60,785 | +582% |
|
|
2
Citadel Advisors
Miami,
Florida
| $41.3K | +$32.6K | +17,764 | +335% |
|
|
HF
3
HRT Financial
New York
| $28K | +$25.1K | +13,657 | +544% |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $14.7K | +$15.1K | +8,213 | New |
|
|
DB
5
Danske Bank
Copenhagen K,
Denmark
| $2 | +$2 | +1 | New |
|
|
XT
6
XTX Topco
George Town,
Cayman Islands
| – | -$22K | -8,379 | Closed |
|
|
7
Renaissance Technologies
New York
| – | -$12.1K | -4,610 | Closed |
|
|
TSS
8
Two Sigma Securities
New York
| – | -$6.67K | -2,534 | Closed |
|
CPHI Hedge Fund Activity: Q2 2025 in Review
5 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q2 2025, worth a combined $212K — up 140% from $88.3K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CPHI and 2 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 3 added.
The largest buyer was UBS Group, adding an estimated $112K. The largest seller was XTX Topco, exiting entirely with an estimated $22K sold.
- 5 institutional investors held China Pharma Holdings (CPHI) as of Q2 2025, down from 6 in Q1 2025.
- Funds reported $212K of China Pharma Holdings stock for Q2 2025, up 140% quarter-over-quarter.
- 2 funds opened new China Pharma Holdings positions in Q2 2025 and 3 closed out, a net change of -1 holder.
- The largest China Pharma Holdings buyer in Q2 2025 was UBS Group, an estimated $112K added.
- The largest China Pharma Holdings seller in Q2 2025 was XTX Topco, an estimated $22K sold.
Based on aggregated 13F filings for Q2 2025.